Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Neoadjuvant Therapy × 30 days × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Cisplatin 4 Platinum 3 Pemetrexed 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 tremelimumab 1 methoxyamine 1 decitabine and cedazuridine drug combination 1 cediranib 1 atezolizumab 1 aldesleukin 1 Radiotherapy 1 Radiation 1 Pharmaceutical Preparations 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Carboplatin 1 Bevacizumab 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡